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wall motion was quantified by both gated SPECT and echocardiography. 
Results: At gated SPECT. SC implantation was scored as effective in terms of improve- 
ment of flow and function at rest in patients #1 and #4. In patients that improved, gated 
SPECT showed a reduction of scar area of 12% and 34% in terms of extension and 
severity, respectively. Patients that did not improve showed more extensive scar area 
and impairment of regional wall motion before surgery than patients that improved after 
SC. At QMCE, SC implantation was scored as effective in terms of flow improvement in 
patients #I,#2 and #4, whereas regional wall motion improved in patient #I only. Fre- 
quent or complex ventricular arrhythmias were not observed at 24-h ECG Halter monitor- 
ing during follow-up. 
Conclusion: In patients with previous myocardial infarctlon and dominance of scar, SC 
Implantation may rever?.e hypoperfusion and regional wall motion abnormalities. HOW- 
ever, extensive scar and severe akinesis seem to benefit less from this procedure. 
1004-99 Remodeling of Radial Artery Anastomosed to Internal 
Thoracic Artery as an I-Composite Grafl 
Shinva Fukui. Koichi Toda. Toshlhiro Funatsu, Kei Horiguchl, Yuji Miyamoto, 
Sakurabashi Watanabe Hospital, Osaka, Japan, Osaka Unwersity Graduate School of 
Medicine, Osaka, Japan 
Background: Internal thoracic artery (ITA) remodels its diameter in response to the flow 
requirement. However, it is unclear whether radial artery (RA) has a capacity for remod- 
eling, when anastomosed to ITA as an l-composite graft. The purpose of this study was 
to elucidate the remodeling of the RA used as an l-composite graft with ITA. Methods: 
We studied 16 consecutive patients who underwent coronary artery bypass grafting 
using RA anastomosed to ITA as an l-composite graft. The diameter of ITA and RA were 
evaluated before surgery and at 3 weeks and 1 year after surgery. Results: The RAs 
were sigmficantly larger in diameter than ITAs (3.5kO.3 mm vs 2.2~tO.3 mm, p<O.OOOl) 
and the ratio of RA to ITA was 1.6 : 1 before surgery Among 16 patients 2 patients had I- 
composite grafts wth left ITA and RA, while 14 patients had l-composite grafts with riaht 
ITA and RA. 15 RAs had two sequential anastomoses and 1 RA had a single anastomo- 
sis. 3 weeks after surgery all grafts were confirmed to be patent by angiography and 
there was no signtficant difference in diameter between RAs and ITAs (2.2kO.5 mm vs 
2.1eO.5 mm). The ratio of RA to ITA significantly reduced to 1.0 : 1 (p=O.OOOS) es com- 
pared wth preoperative ratio. 4 patients were followed a year after surgery. The diameter 
of ITAs and RAs were increased 11 % and IO %, respectively in 3 patients without 
changing the ratio of RA to ITA. Conclusion: This study suggests that RA adjusts the 
diameter in response to the ITA flow, when anastomosed to ITA as an I-composite graft 
These results may support the use of ITA-RA compos!te graft as an extended arterial 
graft with remodeling capacity. 
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1022A-MP-203 E-Selectin Gene Promoter Is a Predictor of Outcome in 
Unstable Angina 
Maria M. Irurita, Florentmo Sanchez, Angel Loma-Ossono, Ana Canas, Angel 
Castaneda. Juncal Irunta. Liduvina Looez. Candida Deniz. Pedro Saavedra. Ricardo 
Chirino, Fernando Ar&, Miguel Iriane, Dr Negrin Hospltal, Las Palmas, Spain, 
Txagorrltxu Hospital, Vitoria, Spain 
Inflammation and genetic factors are attracting increasing interest as dynamic promoters 
of acute coronary syndromes. Searching for a permanent marker of risk we studied two 
inflammation genotypes tumor necrosis factor-alpha (TNF-a) and endothelial selectin (E- 
selectin) in a cohort of 462 patients following uncomplicated unstable angina. 
For this study we compared 135 diabetics (cases 29.2%) here in after “D”, with 327 non- 
diabetics “nD” (controls), with similar age and gender. Allelic frequencies for TNF-a gene 
promoter Tl(G-308) and T2(A-308)(allele TlTT2, presence/absence of restriction frag- 
ment Ncol) were 0.892/0.106 “D” and 0.934/0.066 “nD”. All&c frequencies for CD62 
gene (E-selectin) El(A561) and E2&561)(El/E2. presence/absence of restriction frag- 
ment Pstl were 0.83OIO.170 “D” and 0.888/0.112 “nD”. Genotyping frequencies were in 
Hardy-Weinberg equilibrium. 
Hypertension (67.4 “D” vs. 44.6% “nD”; pcO.0001); smoking (61.5 “D” vs. 48.9% “nD”; 
p-zO.014) or dyslipidemia (55.6 “D” vs. 44.6% “nD”; ~~0.04) and multiple vessel disease 
(44.2 “D” vs. 28.6% “nD”; p<O.O05), were more prevalent in diabetics Variant genotypes 
were significantly higher in dlabetlcs TNF-a (30.4 “D” vs. 21.1% “10”; p<O.O41) and E- 
selectin (20 “D” vs 9.8% “0’; pcO.005). Smoking (p<O.OOS) and variant E-selectin geno- 
types (p<O.OOOl) predicted 78.5% of recurrence (restenosis-angina and myocardial inf- 
arction) in a multivariate logistic regression model (including risk factors, genotypes, 
prematurity and gender). 
In COnclusiOn: our data indicate that diabetic patlents with unstable angina have higher 
prevalence of major risk factors, variant inflammation genotypes and multiple vessel dls- 
ease. E-selectin, is an inexpensive (approximately 5 40/patient) major independent pre- 
dictor of recurrence and may contribute to characterize indlwdual variability in coronary 
heart disease. 
9:15 am 
1022A-MP-204 Admission Glucose, Baseline Glucose Control, and 
Mortality After Acute Myocardial Infarction in Diabetic 
Patients 
Jis J. Caq Michelle Jankowski. Michael Hudson, Frederick Whitehouse, W. Douglas 
Weaver, Henry Ford Hospital, Detroit, Ml 
Background: Clinical observations suggest that admission hyperglycemia is associated 
with increased mortality after acute myocardial infarction (Ml) in patients with diabetes 
mellitus. We investigated the association of admisslon plasma glucose, baseline glucose 
control and In-hospital mortality among diabetic patients following acute Ml. Methods: 
The study population included 827 diabetic patients consecutively admitted to our coro- 
nary care unit for acute Ml from 1997 to 2001. Baseline glucose control was the average 
glycated hemoglobin (HgAl C) within 2 years prior to admission. Multivariate logistic 
regression was used to assess the association of admission glucose, average glucose 
control and in-hospital mortality. Results: 9% of the cohort died after acute Ml. The mean 
admission glucose was 31& 143 mg/dL and 234+ 117 mg/dL for those with and without 
mortality, respectively. In the multivariate analysis, after the conventional risk factors and 
severity of Ml were taken into account, the odds ratios (OR) of admission glucose for the 
risk of subsequent mortality were 1.62 (0.65,4.1), 3.79 (1.78, 8.1) and 3.81 (1.60, 9.10) 
for glucose 200-250 mg/dL, 251-350 mg/dL and = 351 mg/dL compared to glucose<200 
mg/dL respectively. The average HgAlC did not differ significantly between the two 
groups: &I+ 1.7% and 8.3+ 1.8% (p=O.51) for groups with and without mortality. There 
was no independent association between average HgAlC and mortality, [OR of 0.93 
(0.76, 1.15)]. The admission glucose and average HgAlC were not highly correlated 
(Pearson correlation coefficient: 0.22). Conclusion: The admission hyperglycemia was 
associated with increased mortality after acute MI In diabetic patients. Baseline glucose 
control did not correlate with admwion glucose and was not associated with risk of mor- 
tality following acute Ml. 
9:30 a.m. 
1022A-MP-206 Increased Platelet Reactivity in Patients With Diabetes 
and Acute Coronary Syndromes: Direct Effects of 
Glucose Attributable to Its Osmolality 
Friederike K. Keatinq Samer S. Kabbani. Erica L. Grayson, Burton E. Sobel, David J. 
Schneider, University of Vermont, Colchester, VT 
Background: Recurrent cardiac events are prevalent in patients with diabetes mellitus 
who sustain an acute coronary syndrome (ACS). In those without diabetes increased 
platelet activation in response to stimuli (1.e. platelet reactwity) presages such events. In 
patients with diabetes Improved glycemic control decreases subsequent cardiac events 
after myocardial infarction. Accordingly, we characterized platelet reactivity in patients 
with ACS with and without diabetes to determine whether high concentrations of glucose 
per se can increase platelet reactivity. 
Methods: Blood was obtained from patients with ACS with (n=29) and without (n=26) 
diabetes. Platelet reactivity (surface expression of P-selectin in response to a low con- 
centration [0.2 PM] of ADP) was quantified with the use of flow cytometry. Blood from 
healthy volunteers was incubated in the presence of glucose or isosmolar concentrations 
of mannltol and sorbitol (both metabolically inactive agents) for 60 minutes before assay 
of platelet reactivity. 
Results: Platelet reactivity was greater in patients with diabetes (percentage of platelets 
expressing P-selectln after exposure to 0.2 pM ADP =13*8% [SD] compared with 8*6% 
in patients without diabetes, p=O.O2). Addition of glucose to whole blood from healthy vol- 
unteers led to increased platelet reactiwty (fold induction with 27.5 mM 1250 mgibl] = 
1.6eO.2, with 55 mM = 4.131-0.9 [SEMI. n=6, p=O.O03). lsosmolar concentrations of glu- 
cose, sorbitol and mannitol exeried comparable effects (fold induction with 25 mM glu- 
cose = 1.7iO.2, n=lO, sorbitol = 1.9r0.3. n=7, and mannitol = 1 8eO.2 [SEMI, n=8; p < 
0.05 for comparison of each with control). 
Conclusions: Platelet reactivity IS increased in patients with ACS who have diabetes. 
The increased reactivity may contribute to cardiovascular risk. Osmotic effects of hyperg- 
lycemla can increase platelet reactivity directly. 
